Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study

Fertility and Sterility

Volumn 91, Issue 6, 2009, Pages 2537-2544

  Mancini, Fulvia ^a   Cianciosi, Arianna ^a   Marchesini Reggiani, Giulio ^a   Facchinetti, Fabio ^b   Battaglia, Cesare ^a   de Aloysio, Domenico ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

endothelin 1; flow mediated dilatation; homocysteine; Leptin; polycystic ovarian syndrome

Indexed keywords

ANDROGEN; ENDOTHELIN 1; FIBRINOGEN; GLUCOSE; HOMOCYSTEINE; INSULIN; LEPTIN;

ADULT; AMINO ACID BLOOD LEVEL; ANDROGEN BLOOD LEVEL; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEAN BODY WEIGHT; OBESITY; OVARY POLYCYSTIC DISEASE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; VASCULAR ENDOTHELIUM;

ADULT; ANDROGENS; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CASE-CONTROL STUDIES; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOGEN; HOMOCYSTEINE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MENSTRUATION; OVERWEIGHT; POLYCYSTIC OVARY SYNDROME; PROGESTERONE; VASODILATION; YOUNG ADULT;

EID: 67349198880     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.03.023     Document Type: Article

References (38)

1. Meyer C., McGrath B.P., and Teede H.J. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. J Clin Endocrinol Metab 90 (2005) 5711-5716
2. Frühbeck G. A heliocentric view of leptin. Proc Nutr Soc 60 (2001) 301-318
3. Gómez-Ambrosi J., Salvador J., Páramo J.A., Orbe J., de Irala J., Diez-Caballero A., et al. Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. Clin Biochem 35 (2002) 315-320
4. Pasquali R., Gambineri A., and Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG 113 (2006) 1148-1159
5. Welch G.N., and Lo Scalzo J. Homocysteine and atherotrombosis. N Engl J Med 338 (1998) 1042-1050
6. House J.D., Stead L.M., Brosnan M.E., and Brosnan J.T. Regulation of homocysteine metabolism. Adv Enzyme Regul 39 (1999) 69-91
7. Orio Jr. F., Palomba S., Cascella T., De Simone B., Di Biase S., Russo T., et al. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab 89 (2004) 4588-4593
8. Celermajer D.S., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340 (1992) 1111-1115
9. Yanagisawa M., and Masaki T. Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci 10 (1989) 374-378
10. Pierpoint T., McKeigue P., Isaacs A., Wild S., and Jacobs H. Mortality of women with polycystic ovary syndrome at long term follow-up. J Clin Epidemiol 51 (1998) 581-586
11. Battaglia C., Artini P.G., Salvatori M., Giulini S., Petraglia F., Maxia N., et al. Ultrasonographic patterns of polycystic ovaries: color Doppler and hormonal correlations. Ultrasound Obstet Gynecol 11 (1998) 332-336
12. Battaglia C., Mancini F., Cianciosi A., Busacchi P., Facchinetti F., Marchesini Reggiani G., Genazzani A.R., et al. Vascular risk in young women with polycystic ovary and polycystic ovary syndrome. Obstet Gynecol 111 (2008) 385-395
13. Ferriman D., and Gallwey J.D. Clinical assessment of body hair growth in women. J Clin Endocrinol 21 (1971) 1440-1447
14. Battaglia C., Artini P.G., D'Ambrogio G., Genazzani A.D., and Genazzani A.R. The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome. Am J Obstet Gynecol 172 (1995) 108-113
15. Corretti M.C., Anderson T.J., Benjamin E.J., Celermajer D., Charbonneau F., Creager M.A., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol 39 (2002) 257-265
16. Battaglia C., Genazzani A.D., Salvatori M., Giulini S., Artini P.G., Genazzani A.R., et al. Doppler, ultrasonographic and endocrinological enviroment with regard to the number of small subcapsular follicles in polycystic ovary syndrome. Gynecol Endocrinol 13 (1999) 123-129
17. Battaglia C., Regnani G., Mancini F., Iughetti L., Flamigni C., and Venturoli S. Polycystic ovaries in childhood: a common finding in daughters of PCOS patients. A pilot study. Hum Reprod 17 (2002) 771-776
18. Clauss A. Gerinnungsphysiologische Schnellmethode zur bestimmung des Fibrinogens. [Rapid physiological coagulation method in determination of fibrinogen.]. Acta Haematol 17 (1957) 237-246
19. American Diabetes Association. Clinical practice recommendations. Diabetes Care 20 (1997) S1-S70
20. Tarkun I., Arslan B.C., Canturk Z., Turemen E., Sahin T., and Duman C. Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. J Clin Endocrinol Metab 89 (2004) 5592-5596
21. Anderson E.A., and Mark A.L. Flow-mediated and reflex changes in large peripheral artery tone in humans. Circulation 79 (1989) 93-100
22. Mather K.J., Verma S., Corenblum B., and Anderson T.J. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome. J Clin Endocrinol Metab 85 (2000) 1851-1856
23. DiamantiKandarakis E., Spina G., Kouli C., and Migdalis I. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy. J Clin Endocrinol Metab 86 (2001) 4666-4673
24. Zawadski J.K., and Dunaif A. Diagnostic criteria for polycystic ovary syndrome; toward a rational approach. In: Dunaif A., Givens J.R., Haseltine F., and Merriam G. (Eds). Polycystic ovary syndrome (1992), Blackwell Scientific, Boston 377-384
25. Rotterdam ESHRE/ASRM sponsored PCOS consensus workshop. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertil Steril 81 (2004) 19-26
26. Legro R.S. Polycystic ovary syndrome and cardiovascular disease: a premature association?. Endocr Rev 24 (2003) 302-312
27. Carmina E., and Lobo R.A. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril 82 (2004) 661-665
28. Soonthornpun S., Setasuban W., Thamprasit A., Chayanunnukul W., Rattarasarn C., and Geater A. Novel insulin sensitivity index derived from oral glucose tolerance test. J Clin Endocrinol Metab 88 (2003) 1019-1023
29. Sahu A. Minireview: a hypothalamic role in energy balance with special emphasis on leptin. Endocrinology 145 (2004) 2613-2620
30. Chehab F.F., Lim M.E., and Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 12 (1996) 318-320
31. Erturk E., Kuru N., Savci V., Tuncel E., Ersoy C., and Imamoglu S. Serum leptin levels correlate with obesity parameters but not with hyperinsulinism in women with polycystic ovary syndrome. Fertil Steril 82 (2004) 1364-1368
32. Yarali H., Yildirir A., Aybar F., Kabakci G., Bukulmez O., Akgul E., et al. Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertil Steril 76 (2001) 511-516
33. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 338 (1998) 1042-1050
34. Randeva H.S., Lewandowski K.C., Drzewoski J., Brooke-Wavell K., O'Callaghan C., Czupryniak L., et al. Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome. J Clin Endocrinol Metab 87 (2002) 4496-4501
35. Orio Jr. F., Palomba S., Di Biase S., Colao A., Tauchmanova L., Savastano S., et al. Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88 (2003) 673-679
36. Boulman N., Levy Y., Leiba R., Shachar S., Linn R., Zinder O., et al. Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab 89 (2004) 2160-2165
37. Badawy A., State O., El Gawad S., and El Aziz O.A. Plasma homocysteine and polycystic ovary syndrome: the missed link. Eur J Obstet Gynecol Reprod Biol 131 (2007) 68-72
38. Kilic-Okman T., Guldiken S., and Kucuk M. Relationship between homocysteine and insulin resistance in women with polycystic ovary syndrome. Endocr J 51 (2004) 505-508